Emittance Growth during Bunch Compression in the CTF-II

Measurements of the beam emittance during bunch compression in the CLIC Test Facility (CTF-II) are described. The measurements were made with different beam charges and different energy correlations versus the bunch compressor settings which were varied from no compression through the point of full compression and to over-compression. Significant increases in the beam emittance were observed with the maximum emittance occuring near the point of full (maximal) compression. Finally, evaluation of possible emittance dilution mechanisms indicate that coherent synchrotron radiation was the most likely cause

Bunch Compressor Performances at the CLIC Test Facility

The Test Facility of the "Compact Linear Collider" (CLIC) at CERN (CTF), has to prove the feasibility of transporting high charge beams through decelerating structures at 30 GHz to create RF power. This RF power is used to supply, in the final scheme, the cavities of the main linac. To optimise this power generation, a bunch compressor has been installed in the test line. This compressor shortens the electron bunches after creation and acceleration in the RF gun. The compressed bunches are then accelerated by a high gradient cavity (50 MV/m) and transported to a 30 GHz cavity. Compressed bunch length mesurements showed that lengths of 0.6 mm (rms) were obtained at the entrance of 30 GHz cavity for a 10 nC beam. Compression of electron bunches of charges between 2 and 17 nC have also been measured. Emittance measurements were done to study the transverse effects of the bunch compressor on the beam. The use of the code PARMELA allowed the design and optimisation of the chicane. The simulations results have been compared to the experimental measurements

Results from the CLIC Test Facility

In order to study the principle of the Compact Linear Collider (CLIC) based on the Two Beam Acceleration (TBA) scheme at high frequency, a CLIC Test Facility (CTF) has been set-up at CERN. After four years of successful running, the experimental programme is now fully completed and all its objectives reached, particularly the generation of a high intensity drive beam with short bunches by a photo-injector, the production of 30 GHz RF power and the acceleration of a probe beam by 30 GHz structures. A summary of the CTF results and their impact on linear collider design is given. This covers 30 GHz high power testing, study of intense, short single bunches; as well as RF-Gun, photocathode and beam diagnostic developments. A second phase of the test facility (CTF2) is presently being installed to demonstrate the feasibility of the TBA scheme by constructing a fully engineered, 10 m long, test section very similar to the CLIC drive and main linacs, producing up to 480 MW of peak RF power at 30 GHz and accelerating the beam up to 320 MeV. The present status of CTF2 is reported

Nuclear structure and reaction studies at SPIRAL

The SPIRAL facility at GANIL, operational since 2001, is described briefly. The diverse physics program using the re-accelerated (1.2 to 25 MeV/u) beams ranging from He to Kr and the instrumentation specially developed for their exploitation are presented. Results of these studies, using both direct and compound processes, addressing various questions related to the existence of exotic states of nuclear matter, evolution of new "magic numbers", tunnelling of exotic nuclei, neutron correlations, exotic pathways in astrophysical sites and characterization of the continuum are discussed. The future prospects for the facility and the path towards SPIRAL2, a next generation ISOL facility, are also briefly presented.Comment: 48 pages, 27 figures. Accepted for publication in Journal of Physics

Demonstration of two-beam acceleration in CTF II

The second phase of the Compact LInear Collider (CLIC) Test Facility (CTF II) at CERN has demon-strated the feasibility of two-beam acceleration at 30 GHz using a high-charge drive beam, running paral lel to the main beam, as the RF power source. To date accelerating gradients of 59 MV/m at 30 GHz have been achieved. In CTF II, the two beams are generated by 3 GHz RF photo-injectors and are acceler ated in 3 GHz linacs, before injection into the 30 GHz modules. The drive beam linac has to accelerate a 16 ns long train of 48 bunches, each with a nominal charge of 13.4 nC. To cope with the very su bstantial beam-loading special accelerating structures are used (running slightly off the bunch repetition frequency). A magnetic chicane compresses the bunches to less than 5 ps fwhm, this is needed for efficient 30 GHz power generation. The 30 GHz modules are fully-engineered representative sections of CLIC, they include a 30 GHz decelerator for the drive beam, a 30 GHz accelerator for the main beam, high resolution BPM's and a wire-based active align-ment system. The performance achieved so far, as well as the operational experience with the first accelerator of this type, are reported

SPIRAL II Project (electron option) - Preliminary Design Study

This document presents a Preliminary Design Study (PDS) of the electron option of the SPIRAL II project

Bio::Homology::InterologWalk - A Perl module to build putative protein-protein interaction networks through interolog mapping

<p>Abstract</p> <p>Background</p> <p>Protein-protein interaction (PPI) data are widely used to generate network models that aim to describe the relationships between proteins in biological systems. The fidelity and completeness of such networks is primarily limited by the paucity of protein interaction information and by the restriction of most of these data to just a few widely studied experimental organisms. In order to extend the utility of existing PPIs, computational methods can be used that exploit functional conservation between orthologous proteins across taxa to predict putative PPIs or 'interologs'. To date most interolog prediction efforts have been restricted to specific biological domains with fixed underlying data sources and there are no software tools available that provide a generalised framework for 'on-the-fly' interolog prediction.</p> <p>Results</p> <p>We introduce <monospace>Bio::Homology::InterologWalk</monospace>, a Perl module to retrieve, prioritise and visualise putative protein-protein interactions through an orthology-walk method. The module uses orthology and experimental interaction data to generate putative PPIs and optionally collates meta-data into an Interaction Prioritisation Index that can be used to help prioritise interologs for further analysis. We show the application of our interolog prediction method to the genomic interactome of the fruit fly, <it>Drosophila melanogaster</it>. We analyse the resulting interaction networks and show that the method proposes new interactome members and interactions that are candidates for future experimental investigation.</p> <p>Conclusions</p> <p>Our interolog prediction tool employs the Ensembl Perl API and PSICQUIC enabled protein interaction data sources to generate up to date interologs 'on-the-fly'. This represents a significant advance on previous methods for interolog prediction as it allows the use of the latest orthology and protein interaction data for all of the genomes in Ensembl. The module outputs simple text files, making it easy to customise the results by post-processing, allowing the putative PPI datasets to be easily integrated into existing analysis workflows. The <monospace>Bio::Homology::InterologWalk</monospace> module, sample scripts and full documentation are freely available from the Comprehensive Perl Archive Network (CPAN) under the GNU Public license.</p

The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma

INTRODUCTION: The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that alters metabolism by increasing the level of ketone bodies in the blood. KetoCal® (KC) is a nutritionally complete, commercially available 4:1 (fat:carbohydrate+protein) ketogenic formula that is an effective non-pharmacologic treatment for the management of refractory pediatric epilepsy. Diet-induced ketosis causes changes to brain homeostasis that have potential for the treatment of other neurological diseases such as malignant gliomas. METHODS: We used an intracranial bioluminescent mouse model of malignant glioma. Following implantation animals were maintained on standard diet (SD) or KC. The mice received 2×4 Gy of whole brain radiation and tumor growth was followed by in vivo imaging. RESULTS: Animals fed KC had elevated levels of β-hydroxybutyrate (p = 0.0173) and an increased median survival of approximately 5 days relative to animals maintained on SD. KC plus radiation treatment were more than additive, and in 9 of 11 irradiated animals maintained on KC the bioluminescent signal from the tumor cells diminished below the level of detection (p<0.0001). Animals were switched to SD 101 days after implantation and no signs of tumor recurrence were seen for over 200 days. CONCLUSIONS: KC significantly enhances the anti-tumor effect of radiation. This suggests that cellular metabolic alterations induced through KC may be useful as an adjuvant to the current standard of care for the treatment of human malignant gliomas

An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes

Cancers are characterized by non-random chromosome copy number alterations that presumably contain oncogenes and tumor-suppressor genes (TSGs). The affected loci are often large, making it difficult to pinpoint which genes are driving the cancer. Here we report a cross-species in vivo screen of 84 candidate oncogenes and 39 candidate TSGs, located within 28 recurrent chromosomal alterations in ependymoma. Through a series of mouse models, we validate eight new ependymoma oncogenes and ten new ependymoma TSGs that converge on a small number of cell functions, including vesicle trafficking, DNA modification and cholesterol biosynthesis, identifying these as potential new therapeutic targets.We are grateful to F.B. Gertler (Massachusetts Institute of Technology) and S. Gupton (University of North Carolina) for the generous gift of the VAMP7-phlorin construct and the staffs of the Hartwell Center for Bioinformatics and Biotechnology, the Small Animal Imaging Center, the Animal Resources Center, the Cell and Tissue Imaging Center, and the Flow Cytometry and Cell Sorting Shared Resource at St. Jude Children's Research Hospital for technical assistance. This work was supported by grants from the US National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765, R.J.G.), by the Collaborative Ependymoma Research Network (CERN) and by the American Lebanese Syrian Associated Charities (ALSAC)